Home  >  Speakers  >  Thomas Hoeg Jensen
Thomas Hoeg Jensen

Thomas Hoeg Jensen

    PhD
Director, Adjunct Professor | Bagsværd, Copenhagen (Hovedstaden)    Denmark
Pharmacy And Medicine
Pharmacy And Medicine, Drug Discovery,...More
Spoken at 1 event

Biography :

Thomas Hoeg-Jensen has 23 years of experience in design and preparation of diabetes-related peptide and protein drug candidates, and Thomas is co-inventor of insulin degludec (Tresiba) and the basal-bolus co-formulation with insulin aspart (Ryzodeg), both of which are marketed by Novo Nordisk. Thomas is adjunct professor at University of Copenhagen, and apart from drug discovery his research has included novel protein conjugation methods, glucose binding molecules and chemoinformatics systems for chemically modified proteins.

**********************
*** **** ****
 
For speaker's contact information - Contact us

Specialties

Pharmacy and Medicine

Interested Topics

Pharmacy and Medicine, Drug Discovery, Pharmaceutical Industry

State Licenses

This section has yet to be updated by the speaker.

Board Certifications

This section has yet to be updated by the speaker.

Professional Association

This section has yet to be updated by the speaker.

Languages

This section has yet to be updated by the speaker.

Conference Session Materials

The conference session material has yet to be added by the speaker.
X

Send Message

Convert
Onsite to Virtual Conference

Market your online event to Million plus Healthcare professionals.